RESPEDIA

Trademark usage description

human vaccines; vaccine adjuvants pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and de Read More

Classification Information

Class [005]
Human vaccines; vaccine adjuvants

Classification kind code

Class [042]
Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines

Classification kind code

Mark Details

Serial Number

1861733

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 24^th May 2019	Allowed
Submitted for opposition 51 on 24^th May 2019	Allowance Notice Sent
Submitted for opposition 42 on 6^th Feb 2019	Advertised
Submitted for opposition 26 on 17^th Jan 2019	Approved
Submitted for opposition 27 on 30^th Nov 2018	Approval Notice Sent
Submitted for opposition 22 on 25^th Oct 2018	Search Recorded
Submitted for opposition 20 on 25^th Oct 2018	Examiner's First Report
Submitted for opposition 31 on 11^th Oct 2017	Formalized
Submitted for opposition 30 on 10^th Oct 2017	Filed
Submitted for opposition 1 on 10^th Oct 2017	Created

RESPEDIA

Classification Information

Class [005]Human vaccines; vaccine adjuvants

Classification kind code

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Human vaccines; vaccine adjuvants